These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6036726)

  • 1. Biochemical properties of anti-inflammatory drugs. XI. Structure-action relationship for the uncoupling of oxidative phosphorylation and inhibition of chymotrypsin by N-substituted anthranilates and related compounds.
    Whitehouse MW
    Biochem Pharmacol; 1967 May; 16(5):753-60. PubMed ID: 6036726
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical properties of anti-inflammatory drugs. X. The inhibition of serotonin formation in vitro and inhibition of the esterase activity of alpha-chymyotrypsin.
    Skidmore IF; Whitehouse MW
    Biochem Pharmacol; 1967 May; 16(5):737-51. PubMed ID: 6036725
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-inflammatory properties of N-phenylanthranilic acid derivatives in relation to uncoupling of oxidative phosphorylation.
    Saeki K; Muraoka S; Yamasaki H
    Jpn J Pharmacol; 1972 Apr; 22(2):187-99. PubMed ID: 4262661
    [No Abstract]   [Full Text] [Related]  

  • 4. Physicochemical properties and uncoupling activity of 3'-substituted analogues of N-phenylanthranilic acid.
    Terada H; Muraoka S
    Mol Pharmacol; 1972 Jan; 8(1):95-103. PubMed ID: 5061521
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. I. Pharmacology.
    Winder CV
    Ann Phys Med; 1966; Suppl():7-16. PubMed ID: 6004862
    [No Abstract]   [Full Text] [Related]  

  • 6. Uncoupling of oxidative phosphorylation by some fluoro-compounds, notably perfluoropinacol.
    Whitehouse MW; Skidmore IF
    Biochem Pharmacol; 1967 May; 16(5):911-5. PubMed ID: 6036740
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5'-triphosphate.
    Collier HO; James GW; Schneider C
    Nature; 1966 Oct; 212(5060):411-2. PubMed ID: 4381910
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of mefenamic acid and flufenamic acid on plasma uric acid levels.
    Latham BA; Radcliff F; Robinson RG
    Ann Phys Med; 1966 Aug; 8(7):242-3. PubMed ID: 5918265
    [No Abstract]   [Full Text] [Related]  

  • 9. Concerning the regulation of some diverse biochemical reactions underlying the inflammatory response by salicylic acid, phenylbutazone and other acidic antirheumatic drugs.
    Skidmore IF; Whitehouse MW
    J Pharm Pharmacol; 1966 Aug; 18(8):558-60. PubMed ID: 4381870
    [No Abstract]   [Full Text] [Related]  

  • 10. The fibrinolytic activity of anti-inflammatory drugs.
    Gryglewski R
    J Pharm Pharmacol; 1966 Jul; 18(7):474. PubMed ID: 4381731
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of non-steroidal anti-inflammatory drugs in the Evans Blue pleural effusion.
    Sancilio LF; Rodriguez R
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):707-10. PubMed ID: 5959007
    [No Abstract]   [Full Text] [Related]  

  • 12. Fenamates and the potent inhibition of human liver phenol sulphotransferase.
    Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM
    Xenobiotica; 2000 Feb; 30(2):111-6. PubMed ID: 10718119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity.
    Chalmers DK; Scholz GH; Topliss DJ; Kolliniatis E; Munro SL; Craik DJ; Iskander MN; Stockigt JR
    J Med Chem; 1993 Apr; 36(9):1272-7. PubMed ID: 8487264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the fenamates on the threshold of pain.
    Haward LR
    Ann Phys Med; 1966; Suppl():55-7. PubMed ID: 4895007
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-complement effects of two anti-inflammatory agents. Niflumic and flufenamic acids.
    Harrity TW; Goldlust MB
    Biochem Pharmacol; 1974 Nov; 23(22):3107-20. PubMed ID: 4216354
    [No Abstract]   [Full Text] [Related]  

  • 16. BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY.
    WHITEHOUSE MW
    Biochem Pharmacol; 1964 Mar; 13():319-36. PubMed ID: 14157591
    [No Abstract]   [Full Text] [Related]  

  • 17. Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium.
    Sanger GJ; Bennett A
    Br J Clin Pharmacol; 1979 Nov; 8(5):479-82. PubMed ID: 508555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs.
    Inglot AD
    J Gen Virol; 1969 Mar; 4(2):203-14. PubMed ID: 4306296
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of enzyme release from isolated rat liver lysosomes by non-steroidal anti-inflammatory drugs.
    Tanaka K; Iizuka Y
    Biochem Pharmacol; 1968 Oct; 17(10):2023-32. PubMed ID: 5696873
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-oxidative profile of lobenzarit disodium (CCA).
    Cynshi O; Saitoh M; Cynshi F; Tanemura M; Hata S; Nakano M
    Biochem Pharmacol; 1990 Nov; 40(9):2117-22. PubMed ID: 2242038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.